Literature DB >> 15810000

Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility.

Susan Thomas Vadaparampil1, Louise Wideroff, Lorayn Olson, K Viswanath, Andrew N Freedman.   

Abstract

Commercial marketing materials may serve as a source of information for physicians about genetic testing for inherited cancer susceptibility (GTICS) in addition to medical guidelines, continuing education, and journal articles. The primary purposes of this study were to: (1) determine the percentage of physicians who received advertisements for GTICS early in the diffusion of commercial GTICS (1999-2000); (2) assess associated characteristics; and (3) measure the perceived importance of commercial advertisements and promotions in physicians' decisions to recommend testing to patients. A nationally representative, stratified random sample of 1,251 physicians from the American Medical Association (AMA) Physician Masterfile completed a 15-20 min mixed mode questionnaire that assessed specialty, previous use of genetic tests, practice characteristics, age, and receipt of advertising materials (response rate = 71%). Overall, 27.4% (n = 426) had received advertisements. In multivariate analysis, factors associated with receipt of advertisements included: specialties in obstetrics/gynecology, oncology, or gastroenterology; past GTICS use, and age 50+. One of four felt that advertisements would be important in their decision to recommend GTICS. Study results indicate that physicians, particularly in oncology, obstetrics/gynecology, and gastroenterology, began receiving GTICS advertisements commensurate with the early diffusion of commercially available tests into clinical practice. At that time, one-quarter of the physicians considered advertisements to play an important role in their clinical decision making, suggesting attention to other sources of information and additional factors. Published 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15810000     DOI: 10.1002/ajmg.a.30681

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

Review 1.  Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.

Authors:  Kathryn A Phillips; Su-Ying Liang; Stephanie Van Bebber
Journal:  Curr Opin Mol Ther       Date:  2008-06

2.  A theory-informed systematic review of clinicians' genetic testing practices.

Authors:  Jean L Paul; Hanna Leslie; Alison H Trainer; Clara Gaff
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

3.  Physician Risk Assessment Knowledge Regarding BRCA Genetics Testing.

Authors:  Jason Cohn; William Blazey; David Tegay; Brian Harper; Sharon Koehler; Brookshield Laurent; Vivian Chan; Min-Kyung Jung; Bhuma Krishnamachari
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

Review 4.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

5.  Impact of web-based case conferencing on cancer genetics training outcomes for community-based clinicians.

Authors:  Kathleen R Blazer; Christina Christie; Gwen Uman; Jeffrey N Weitzel
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

6.  Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives.

Authors:  Elizabeth Spellman; Nadiyah Sulayman; Susan Eggly; Beth N Peshkin; Claudine Isaacs; Marc D Schwartz; Suzanne C O'Neill
Journal:  Psychooncology       Date:  2013-02-28       Impact factor: 3.894

7.  A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.

Authors:  Tuya Pal; Deborah Cragun; Courtney Lewis; Andrea Doty; Maria Rodriguez; Cristi Radford; Zachary Thompson; Jongphil Kim; Susan T Vadaparampil
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-28

Review 8.  A health services research agenda for cellular, molecular and genomic technologies in cancer care.

Authors:  Louise Wideroff; Kathryn A Phillips; Gurvaneet Randhawa; Anita Ambs; Katrina Armstrong; Charles L Bennett; Martin L Brown; Molla S Donaldson; Michele Follen; Sue J Goldie; Robert A Hiatt; Muin J Khoury; Graham Lewis; Howard L McLeod; Margaret Piper; Isaac Powell; Deborah Schrag; Kevin A Schulman; Joan Scott
Journal:  Public Health Genomics       Date:  2009-02-20       Impact factor: 2.000

9.  Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce.

Authors:  Kathleen R Blazer; Deborah J Macdonald; Julie O Culver; Carin R Huizenga; Robert J Morgan; Gwen C Uman; Jeffrey N Weitzel
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

10.  Electronic health record interventions at the point of care improve documentation of care processes and decrease orders for genetic tests commonly ordered by nongeneticists.

Authors:  Maren T Scheuner; Jane Peredo; Kelly Tangney; Diane Schoeff; Taylor Sale; Caroline Lubick-Goldzweig; Alison Hamilton; Lee Hilborne; Martin Lee; Brian Mittman; Elizabeth M Yano; Ira M Lubin
Journal:  Genet Med       Date:  2016-06-30       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.